News | 2021.06.03
The three-year collaboration agreement signed on March 31, 2021 between the Institut Pasteur, the Paris Public Hospital Network (AP-HP) and Janssen Biotech, Inc., the R&D partner of Janssen France, one of the pharmaceutical companies in the Johnson & Johnson group, paves the way for research into the signaling pathways involved in chronic inflammatory rheumatic diseases.One of the aims of...
News | 2021.05.31
Diphtheria is a severe infection caused in humans by toxigenic strains of Corynebacterium diphtheriae bacteria. If left untreated, it leads to death in 5 to 25% of cases. It generally affects the upper respiratory tracts, causing pseudomembrane formation and sometimes leading to suffocation. The infection can be complicated by systemic symptoms caused by the diphtheria toxin. Scientists from the...
Document de presse | 2021.05.28
The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world. It is now dominant in many countries and regions (India, the UK, Portugal, Russia, etc.) and is predicted to be the most prevalent variant in Europe within weeks or months. Epidemiological studies have shown that the Delta variant is more transmissible than other variants....
News | 2021.07.21
Over the last few decades, neurodegenerative diseases became one of the top 10 global causes of death. Researchers worldwide are making a strong effort to understand neurodegenerative diseases pathogenesis, which is essential to develop efficient treatments against these incurable diseases. However, our knowledge about the basic molecular mechanisms underlying the pathogenesis of...
News | 2021.06.10
The Search Committee for Director of the Institute Pasteur invites expressions of interest from potential candidates for the position of Director of the Institute. The Search Committee for Director of the Institute Pasteur welcomes letters of interest accompanied by curriculum vitae. Please send all letters and other inquiries by e-mail to searchcommittee2021@pasteur.fr. I. Pasteur Search...
Document de presse | 2021.05.27
A study conducted by the University Hospital of Strasbourg (HUS) in collaboration with the Institut Pasteur, published as a preprint on medRxiv, has led to a significant advance in knowledge about COVID-19.In connection with the SeroCoV-HUS study led by Professor Samira Fafi-Kremer (University Hospital of Strasbourg (HUS) – University of Strasbourg – INSERM UMR1109), the team at Strasbourg...
Document de presse | 2021.06.07
To enable tissue renewal, human tissues constantly eliminate millions of cells, without jeopardizing tissue integrity, form and connectivity. The mechanisms involved in maintaining this integrity remain unknown. Scientists from the Institut Pasteur and the CNRS today revealed a new process which allows eliminated cells to temporarily protect their neighbors from cell death, thereby maintaining...
News | 2020.12.01
AVATAR MEDICAL uses virtual and augmented reality to offer surgeons an immersive, interactive preoperative visualization of 3D medical images of patients obtained with MRI or CT scans.The solution gives physicians the opportunity to view organs, blood vessels and tumors and to prepare for complex medical procedures by navigating effortlessly through all the data, with no pre-processing required....
News | 2021.06.01
French health authorities updated their map showing the spread of the tiger mosquito in France. On 1st of January 2021, 64 of the country's départements on "red alert", six more than on 1st of January 2020. Present in France since 2004, the Aedes albopictus mosquito is originally from Asia and is the vector for diseases such as dengue, chikungunya and Zika.In 2021, the tiger mosquito (...
Article | 2021.06.24
In December 2021, the Institut Pasteur gained the HR Excellence in Research Award from the European Commission and has embarked on a process of continuous improvement regarding recruitment and working conditions for scientists, while strengthening its attractiveness at the international level.